Shandong Kexing Bioproducts Co. Ltd. A (688136 SHG) stock market data APIs
¥42.6235
0.05(0.1%)
as of September 15, 2025
Try our APIs with
free plan!
Shandong Kexing Bioproducts Co. Ltd. A Financial Data Overview
Price chart is built with
Anychart
Kexing Biopharm Co., Ltd. engages in the research and development, production, and sale of recombinant protein drugs and microbial preparations in China and internationally. The company focuses on pharmaceutical research in the therapeutic fields of antiviral, tumor and immunity, blood, digestion, and degenerative diseases. Its products include recombinant human interferon a1b, human erythropoietin, and human granulocyte stimulating factor; Clostridium butyricum combined live bacteria powder; Kehuang Capsule, a Chinese patent medicine; Entecavir, a chemical drug; and liraglutide, a human glucagon-like peptide-1, as well as Albumin-Paclitaxel, Infliximab, Bevacizumab, adalimumab, trastuzumab, neratinib maleate tablets, and lenalidomide capsules. The company was founded in 1989 and is based in Jinan, China.
Prev. Close
42.6235
Open
42.6726
High
43.946
Low
40.7905
52 wk Range
13.5176-63.2764
Market Cap
8 555 M
P/E Ratio
85.02
Shares Outstanding
201 M
Revenue
1 347 M
EPS
-0.0441
Dividends (Yield)
0.002
Beta
0.878
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shandong Kexing Bioproducts Co. Ltd. A data using free add-ons & libraries
Get Shandong Kexing Bioproducts Co. Ltd. A Fundamental Data
Shandong Kexing Bioproducts Co. Ltd. A Fundamental data includes:
- Net Revenue: 1 347 M
- EBITDA: 170 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-03-31
- EPS/Forecast: NaN
Get Shandong Kexing Bioproducts Co. Ltd. A End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shandong Kexing Bioproducts Co. Ltd. A News
New
IQVIA Holdings (IQV) Announces CFO Transition With Michael Fedock Succeeding Ron Bruehlman
IQVIA Holdings recently appointed Michael Fedock as the future CFO, replacing the retiring Ron Bruehlman, marking a significant leadership transition. The company's shares rose 29% last quarter, a per...
IQVIA Holdings (IQV) Enters Partnership With Kexing Biopharm To Enhance Drug Development
IQVIA Holdings recently forged a strategic partnership with Kexing Biopharm, aiming to bolster the clinical development and market integration of innovative therapeutics globally. Over the last quarte...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
